Evidence map›Paper›PMID 38480715›Full record

ArticleNature communications2024

The decline of the 2022 Italian mpox epidemic: Role of behavior changes and control strategies.

Giorgio Guzzetta, Valentina Marziano, Alessia Mammone, Andrea Siddu, Federica Ferraro, Anna Caraglia, Francesco Maraglino, Giovanni Rezza, Alessandro Vespignani, Ira Longini and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Mechanics of pandemics.EClinicalMedicine · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Relationship dynamics and behavioral adaptations in the control of the 2022 mpox epidemic.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  15. Review
  16. Article
  17. Modelling international spread of clade IIb mpox on the Asian continent.Bulletin of the World Health Organization · 2025
    Article
  18. Article
  19. Review
  20. Current advances and challenges in mpox vaccine development: a global landscape.Therapeutic advances in vaccines and immunotherapy · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Giorgio GuzzettaCenter for Health Emergencies, Bruno Kessler Foundation, Trento, Italy.ORCID 0000-0002-9296-9470
Valentina MarzianoCenter for Health Emergencies, Bruno Kessler Foundation, Trento, Italy.ORCID 0000-0003-2842-7906
Alessia MammoneHealth Prevention Directorate, Ministry of Health, Rome, Italy.
Andrea SidduHealth Prevention Directorate, Ministry of Health, Rome, Italy.
Federica FerraroHealth Prevention Directorate, Ministry of Health, Rome, Italy.
Anna CaragliaHealth Prevention Directorate, Ministry of Health, Rome, Italy.
Francesco MaraglinoHealth Prevention Directorate, Ministry of Health, Rome, Italy.
Giovanni RezzaHealth Prevention Directorate, Ministry of Health, Rome, Italy.
Alessandro VespignaniLaboratory for the Modeling of Biological and Socio-Technical Systems, Northeastern University, Boston, MA, USA.ORCID 0000-0003-3419-4205
Ira LonginiDepartment of Biostatistics, Colleges of Public Health and Health Professions, and Medicine, University of Florida, Gainesville, FL, USA.
Marco AjelliLaboratory for Computational Epidemiology and Public Health, Department of Epidemiology and Biostatistics, Indiana University School of Public Health, Bloomington, IN, USA.ORCID 0000-0003-1753-4749
Stefano MerlerCenter for Health Emergencies, Bruno Kessler Foundation, Trento, Italy. merler@fbk.eu.ORCID 0000-0002-5117-0611
Ministero della Salute · ITFondazione Bruno Kessler · ITIndiana University Bloomington · USNortheastern University · USUniversity of Florida · USVita-Salute San Raffaele University · IT

Funding

EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 101045989 (VERDI)
6 · The paper itself

Abstract

In 2022, a global outbreak of mpox occurred, predominantly impacting men who have sex with men (MSM). The rapid decline of this epidemic is yet to be fully understood. We investigated the Italian outbreak by means of an individual-based mathematical model calibrated to surveillance data. The model accounts for transmission within the MSM sexual contact network, in recreational and sex clubs attended by MSM, and in households. We indicate a strong spontaneous reduction in sexual transmission (61-87%) in affected MSM communities as the possible driving factor for the rapid decline in cases. The MSM sexual contact network was the main responsible for transmission (about 80%), with clubs and households contributing residually. Contact tracing prevented about half of the potential cases, and a higher success rate in tracing contacts could significantly amplify its effectiveness. Notably, immunizing the 23% of MSM with the highest sexual activity (10 or more partners per year) could completely prevent new mpox resurgences. This research underscores the importance of augmenting contact tracing, targeted immunization campaigns of high-risk groups, and fostering reactive behavioral changes as key strategies to manage and prevent the spread of emerging sexually transmitted pathogens like mpox within the MSM community.

Indexed as

HIV InfectionsMpox, MonkeypoxSexual and Gender MinoritiesHomosexuality, MaleHumansItalyMaleSexual Behavior

Identifiers

PMID38480715
PMCPMC10937928
OpenAlexW4392747573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.